RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
RxSight (NASDAQ: RXST), an ophthalmic medical device company focused on post-cataract surgery customized vision solutions, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference.
The company's management will engage in a fireside chat scheduled for April 8, 2025, at 9:45 AM PT / 12:45 PM ET. Interested parties can access both the live presentation and archived recording through RxSight's investor relations website at https://investors.rxsight.com/.
RxSight (NASDAQ: RXST), un'azienda di dispositivi medici oftalmici focalizzata su soluzioni visive personalizzate post-chirurgia catarattica, ha annunciato la sua partecipazione alla 24ª Conferenza Virtuale Annuale di Needham sulla Salute.
La direzione dell'azienda parteciperà a una chiacchierata informale programmata per l'8 aprile 2025, alle 9:45 AM PT / 12:45 PM ET. Le parti interessate possono accedere sia alla presentazione in diretta che alla registrazione archiviata attraverso il sito web delle relazioni con gli investitori di RxSight all'indirizzo https://investors.rxsight.com/.
RxSight (NASDAQ: RXST), una empresa de dispositivos médicos oftálmicos enfocada en soluciones de visión personalizadas post-cirugía de cataratas, ha anunciado su participación en la 24ª Conferencia Virtual Anual de Salud de Needham.
La dirección de la empresa participará en una charla informal programada para el 8 de abril de 2025, a las 9:45 AM PT / 12:45 PM ET. Las partes interesadas pueden acceder tanto a la presentación en vivo como a la grabación archivada a través del sitio web de relaciones con inversores de RxSight en https://investors.rxsight.com/.
RxSight (NASDAQ: RXST), 백내장 수술 후 맞춤형 시력 솔루션에 중점을 둔 안과 의료 기기 회사가 제24회 니드햄 연례 가상 의료 회의에 참여한다고 발표했습니다.
회사의 경영진은 2025년 4월 8일 오전 9시 45분 PT / 오후 12시 45분 ET에 예정된 파이어사이드 챗에 참여할 예정입니다. 관심 있는 당사자는 RxSight의 투자자 관계 웹사이트 https://investors.rxsight.com/를 통해 실시간 발표 및 아카이브된 녹화에 접근할 수 있습니다.
RxSight (NASDAQ: RXST), une entreprise de dispositifs médicaux ophtalmiques axée sur des solutions de vision personnalisées après une chirurgie de la cataracte, a annoncé sa participation à la 24e Conférence Virtuelle Annuelle de Needham sur la Santé.
La direction de l'entreprise participera à une discussion informelle prévue pour le 8 avril 2025, à 9h45 PT / 12h45 ET. Les parties intéressées peuvent accéder à la fois à la présentation en direct et à l'enregistrement archivé via le site web des relations avec les investisseurs de RxSight à l'adresse https://investors.rxsight.com/.
RxSight (NASDAQ: RXST), ein Unternehmen für ophthalmologische Medizintechnik, das sich auf maßgeschneiderte Sehlösungen nach Kataraktoperationen konzentriert, hat seine Teilnahme an der 24. jährlichen virtuellen Gesundheitskonferenz von Needham bekannt gegeben.
Das Management des Unternehmens wird an einem informellen Gespräch teilnehmen, das für den 8. April 2025, um 9:45 Uhr PT / 12:45 Uhr ET geplant ist. Interessierte Parteien können sowohl auf die Live-Präsentation als auch auf die archivierte Aufzeichnung über die Investor-Relations-Website von RxSight unter https://investors.rxsight.com/ zugreifen.
- None.
- None.
ALISO VIEJO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming 24th Annual Needham Virtual Healthcare Conference.
RxSight’s management is scheduled to participate in a fireside chat on Tuesday, April 8, 2025, at 9:45 a.m. Pacific Time / 12:45 p.m. Eastern Time. A live and archived webcast of the presentation will be available on the Company’s investor relations website at https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL™/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
When is RxSight (RXST) presenting at the Needham Healthcare Conference 2025?
How can investors watch RxSight's (RXST) Needham Conference presentation?
What type of medical devices does RxSight (RXST) specialize in?
Which healthcare conference is RxSight (RXST) participating in?
